Literature DB >> 12134987

Intranasal endoscopic diagnosis and treatment in congenital nasolacrimal duct obstruction.

Woong C Choi1, Kyu S Kim, Tae K Park, Chun Suk Chung.   

Abstract

BACKGROUND AND
OBJECTIVE: To identify the causes of congenital nasolacrimal duct obstruction using intranasal endoscopy. PATIENTS AND METHODS: Eleven children with symptoms of epiphora since birth were selected for treatment. A silicone tube was inserted after identifying the causes of prior probing failures by observing the probing tip directly with intranasal endoscopy.
RESULTS: As confirmed through intranasal endoscopic examination, tearing was caused by mucosal obstruction, submucosal passing of the probe, pus collection, and inferior turbinate impaction. The probe passed into the submucosal space in 5 patients and, by performing probing medially instead in the usual posterolateral direction, probing succeeded in 4 patients. One case was accompanied by a bone abnormality; we bent the probe tip into the nasal cavity to form the lacrimal pathway.
CONCLUSION: By using intranasal endoscopy, a silicone tube can be inserted under direct visualization and any causative abnormalities can be identified. This can also minimize the intranasal trauma sometimes caused by blind probing.

Entities:  

Mesh:

Year:  2002        PMID: 12134987

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers        ISSN: 1082-3069


  3 in total

1.  Clinical outcomes of initial and repeated nasolacrimal duct office-based probing for congenital nasolacrimal duct obstruction.

Authors:  Deok Sun Cha; Hwa Lee; Min Soo Park; Jong Mi Lee; Se Hyun Baek
Journal:  Korean J Ophthalmol       Date:  2010-10-05

2.  Late and very late initial probing for congenital nasolacrimal duct obstruction: what is the cause of failure?

Authors:  M B Kashkouli; B Beigi; M M Parvaresh; A Kassaee; Z Tabatabaee
Journal:  Br J Ophthalmol       Date:  2003-09       Impact factor: 4.638

3.  Nasal endoscopy in the management of congenital nasolacrimal duct obstruction.

Authors:  Yasser H Al-Faky
Journal:  Saudi J Ophthalmol       Date:  2013-11-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.